My Favorite Dividend King to Buy in November [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
However, arguably the next best thing is for a company to belong to the elite group known as Dividend Kings . To qualify, a company must increase its dividend for at least 50 consecutive years. Most income investors will sleep better at night knowing that a stock has such an impressive dividend track record. Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day. Sign Up For Free » But some Dividend Kings are better than others. Which is the best pick right now? Here's my favorite Dividend King to buy in November. Technically, AbbVie (NYSE: ABBV) has only been around since 2013. That doesn't mean the big pharmaceutical company can't be a Dividend King, though. AbbVie's business operated for decades as part of Abbott Laboratories before being spun off as a separate publicly traded entity 11 years ago. AbbVie, therefore, inherits the rich dividend history of its parent. In September, Abbott announced its 52nd consecutive annual dividend increase
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- 2 Dividend Kings to Buy for a Lifetime of Passive Income [Yahoo! Finance]Yahoo! Finance
- Smart Medical Devices Business Research Report 2024-2030 - Rising Demand for AI-Driven Diagnostics, Self-Tracking, and Digital Therapeutics Generates Market Opportunities [Yahoo! Finance]Yahoo! Finance
- Blood Cancer Diagnostics Market to hit USD 22.2 billion by 2032, says Global Market Insights Inc. [Yahoo! Finance]Yahoo! Finance
- Embolotherapy Business Research Report 2024-2030: Shift Toward Outpatient and Ambulatory Care Settings for Embolotherapy Procedures Expands Access and Drives Cost-Effective Healthcare Delivery [Yahoo! Finance]Yahoo! Finance
- Endocrinology Drugs Market Analysis by Therapy Area, Distribution Channel and Region - A Forecasted $53.85 Billion Industry by 2030 [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 10/16/24 - Beat
ABT
Sec Filings
- 11/15/24 - Form 8-K
- 11/4/24 - Form 144
- 10/31/24 - Form 10-Q
- ABT's page on the SEC website